The term eosinophilic bronchitis is reserved for patients who again respond to anti-asthma medication but do not exhibit either bronchoconstriction or bronchial hyperresponsiveness. As the term implies sputum examination reveals eosinophils. Whether eosinophilic bronchitis represents a separate disease or is part of a spectrum of asthma is hotly debated and obviously depends on which definition of asthma is used. Patients with eosinophilic bronchitis may be relatively resistant to anti-asthma therapy, only responding to high doses of parenteral steroids or more severe immunosuppression. Attempting to control the disease is important since a proportion of these patients do on to develop fixed airflow obstruction or bronchiectasis.
The following events are predicted for almost any cancer victim. The symptoms follow a pattern that is common to death and dying and may occur in any type of death event. They may also occur in any order, and may skip through a predicted episode completely. These phases may last for many months, or they may be briefly expressed.
Lung cancer’s obvious symptom is shortness of breath. As the malignant cells invade the lung tissue and build masses, the lungs are increasingly unable to process the exchange of air. Sometimes the tumors obstruct the airways. Fluid builds up in the lungs. Cancer tumors are fragile and often bleed causing the person to cough up blood.